ATC Group: D10AF01 Clindamycin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D10AF01 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D10 Anti-acne preparations
3 D10A Anti-acne preparations for topical use
4 D10AF Antiinfectives for treatment of acne
5 D10AF01 Clindamycin

Active ingredients in D10AF01

Active Ingredient Description
Clindamycin

Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.

Related product monographs

Title Information Source Document Type  
CLINDAMYCIN Capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CLINDAMYCIN Solution for Injection or Infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DALACIN C Capsule Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
DALACIN CREAM Vaginal Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DALACIN T Topical solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ZINDACLIN Gel Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Finland (FI)

France (FR)

Italy (IT)

Japan (JP)

Lithuania (LT)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Romania (RO)

South Africa (ZA)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.